Finanzas de DENTSPLY SIRONA Inc (XRAY)XRAYDENTSPLY SIRONA Inc

DENTSPLY SIRONA Inc. (XRAY) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Implants & Prosthetics, accounting for 17.5% of total sales, equivalent to $157.00M. Other significant revenue streams include Equipment & Instruments and CAD/CAM. Understanding this composition is critical for investors evaluating how XRAY navigates market cycles within the Medical Equipment, Supplies & Distribution industry.

Evaluating the bottom line, DENTSPLY SIRONA Inc. maintains a gross margin of 54.90%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 9.35%, while the net margin is 4.01%. These profitability ratios, combined with a Return on Equity (ROE) of -32.98%, provide a clear picture of how effectively XRAY converts its operational activities into shareholder value.

In the context of the broader market, XRAY competes directly with industry leaders such as BFLY and ESTA. With a market capitalization of $2.31B, it holds a significant position in the sector. When comparing efficiency, XRAY's gross margin of 54.90% stands against BFLY's 71.41% and ESTA's 70.64%. Such benchmarking helps identify whether DENTSPLY SIRONA Inc. is trading at a premium or discount relative to its financial performance.

DENTSPLY SIRONA reported a gross margin improvement to 56.4% in Q2 2026, despite a revenue decline. Free cash flow rose significantly to $55 million, showing better cash management.